Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil

Clinical Rheumatology

Volumn 23, Issue 1, 2004, Pages 52-56

  Jendro, Michael C ^a,b   Zeidler, Henning ^a   Rosenthal, Herbert ^a   Haller, Hermann ^a   Schwarz, Anke ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Arthropathy; Erdheim Chester disease; Histiocytosis; Mycophenolat mofetil; Vinblastine

Indexed keywords

ALENDRONIC ACID; AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TAMOXIFEN; VINBLASTINE;

ADULT; ARTHRALGIA; ARTICLE; BONE BIOPSY; BONE PAIN; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; ERDHEIM CHESTER DISEASE; EVIDENCE BASED MEDICINE; FIBROSIS; FOLLOW UP; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; LEG PAIN; MALE; OSTEOSCLEROSIS; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS; SYMPTOMATOLOGY; SYSTEMIC DISEASE; URETER OBSTRUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ERDHEIM-CHESTER DISEASE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISOLONE; TREATMENT OUTCOME; VINBLASTINE;

EID: 1342284094     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-003-0801-7     Document Type: Article

References (20)

1. Chester W (1930) Über Lipoidgranulomatose. Virchows Arch Pathol Anat 279:561-602
2. Jaffé HL (1972) Gaucher's disease and certain other inborn metabolic disorders: lipid (cholesterol) granulomatosis. In: Jaffé HL. Metabolic, degenerative and inflammatory diseases of bone and joints. Philadelphia, Lea & Febiger, pp 535-541
3. Ammann P, Bosch B, Buchholz S, Genoni M, Laube I, Naegeli B (2001) Cardiac tumor due to Erdheim-Chester disease. Am J Med 111:672-673
4. Cline MJ (1994) Histiocytes and histiocytosis. Blood 84:2840-2853
5. Kenn W, Eck M, Allolio B et al. (2000) Erdheim-Chester disease: ecidence for a disease entity different from Langerhans' cell histiocytosis? Three cases with detailed radiological and immunohistochemical analysis. Hum Pathol 31:734-739
6. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D et al. (1996) Erdheim-Chester disease: clinical and radiologic characteristics of 59 cases. Medicine 75:157-169
7. Kujat C, Martin J, Püschel W (1991) Die Erdheim-Chester-Krankheit. Radiologe 31:297-306
8. Kujat C, Junk B, Hermes M, Martin J, Dewes W (1991) Zerebrale Manifestationen der Erdheim-Chester-Krankheit. Radiologe 31:307-309
9. Nadre M, Delevaux I, de Fraissinette B et al. (2001) Two enlarged kidneys: A manifestation of Erdheim-Chester disease. Am J Nephrol 21:315-317
10. Ono K, Oshiro M, Uemura KI et al. (1996) Erdheim-Chester disease: A case report with immunohistochemical and biochemical examination. Hum Pathol 27:91-95
11. Rush WL, Andriko JA, Galateau-Salle F et al. (2000) Pulmonary pathology of Erdheim-Chester disease. Mod Pathol 13:747-754
12. Gupta A, Kelly B, McGuigan JE (2002) Erdheim-Chester disease with prominent pericardial involvement: clinical, radiologic, and histologic findings. Am J Med Sci 324:96-100
13. Neame RL, Struthers GR (2003) Erdheim-Chester disease with early onset atherosclerosis and a pseudo-malignant phase. Ann Rheum Dis 62:271-272
14. Serpatrice J, Granel B, De Roux C et al. (2000) 'Coated aorta': A new sign of Erdheim-Chester disease. J Rheumatol 27:1550-1553
15. Breuil V, Brocq O, Pellegrino C, Grimaud A, Euller-Ziegler L (2002) Erdheim-Chester disease: typical radiological bone features for a rare xanthogranulomatosis. Ann Rheum Dis 61:199-200
16. Mossetti G, Rendina D, Numis FG, Somma P, Postiglione L, Nunziata V (2003) Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin-6 soluble receptor and bisphosphonate treatment in Erdheim-Chester disease. Clin Exp Rheumatol. 21:232-236
17. Boissel N, Wechsler B, Leblond V (2001) Treatment of refractory Erdheim-Chester disease with double autologous hematopoetic stem-cell transplantation. Ann Intern Med 135:844-845
18. Schmidt HHJ, Gregg RE, Shamburek R, Brewer BHB, Zech LA (1997) Erdheim-Chester disease: Low low-density lipoprotein levels due to rapid catabolism. Metabolism 46:1215-1219
19. Ladisch S, Gadner H, Arico M et al. (1994) LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans' cell histiocytosis. The Histiocyte Society. Med Pediatr Oncol 23:107-110
20. Grotz W, Von Zedtwitz I, Andre M, Schollmeyer P (1998) Treatment of retroperitoneal fibrosis by mycophenolate mofetil and corticosteroids. Lancet 352:1195